{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

2025 Update in Hematology and Medical Oncology — On Demand


2025 Update in Hematology and Medical Oncology — On Demand Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Course Content


Date & Location
Friday, April 4, 2025, 9:00 AM - Sunday, November 30, 2025, 2:45 PM

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

This 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology offers an in-depth and current review of the diagnosis, staging, and management of neoplastic diseases, encompassing both solid tumors and hematologic malignancies. Expert-led lectures cover disease-specific topics across gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system cancers, as well as hematologic malignancies. View the brochure for a full list of topics covered in this program.

This program is designed for medical oncology professionals—including physicians, nurses, pharmacists, fellows, and residents—and supports preparation for the American Board of Internal Medicine (ABIM) certification and recertification examinations in Hematology and Medical Oncology.

This program was originally recorded live from March 7–10, 2025. Access to the on-demand content and the ability to claim credit will be available through November 30, 2025.
Objectives
At the conclusion of this program, attendees will be able to:

  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice.
  3. Prepare for American Board of Internal Medicine (ABIM) certification and recertification examinations in medical oncology and hematology.

Registration

To enroll, please click the "Register" tab at the top of the page. Once registered, all materials—including instructions for claiming credit—will be available under the "Course Content" tab. On-demand access and the ability to claim credit will remain available through November 30, 2025. 

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

On Demand Access Fees

  • Physicians (MDs, PhDs, and DOs): $2,000
  • APPs, Residents, Fellows, Nurses, and Other Healthcare Providers: $1,075
  • MSK Employees: Complimentary

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 34.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Recorded/Review Date: March 7-10, 2025 | Original Release Date: April 4, 2025 | Termination Date: November 30, 2025



Keywords: AMA PRA Category 1On DemandEnduring Material



Course Directors 

David H. Ilson, MD, PhD, FACP, FASCO
Attending Physician, Member, Gastrointestinal Oncology Service 
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College


Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care; 
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College

 

Course Faculty

Ghassan K. Abou-Alfa, MD, JD, MBA
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor, Weill Cornell College at Cornell University
Adjunct Professor of Medical Diplomacy, Trinity College Dublin


Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service;
Avon Chair in Gynecologic Oncology Research
Memorial Sloan Kettering Cancer Center

P. Dayand Borge, MD, PhD
Chief, Transfusion Medicine and Cell Therapy Service
Memorial Sloan Kettering Cancer Center

Lior Z. Braunstein, MD
Associate Attending Radiation Oncologist, External Beam Radiotherapy Service
Memorial Sloan Kettering Cancer Center

Andrea Cercek, MD
Section Head, Colorectal Cancer;
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers;
Associate Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Alissa J. Cooper, MD
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center

Susanna Curtis, MD, PhD
Assistant Professor of Medicine, Hematology and Medical Oncology;
Assistant Director, The Mount Sinai Comprehensive Sickle Cell Program
Icahn School of Medicine at Mount Sinai 

Joshua Z. Drago, MD, MS
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center

Lara A. Dunn, MD
Assistant Attending Physician, Head and Neck Oncology Service
Memorial Sloan Kettering Cancer Center

Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medical College

Devika Gajria, MD
Medical Site Director, MSK Bergen;
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center

Mark B. Geyer, MD
Adolescent and Young Adult Program Leader;
Adult Lymphoblastic Leukemia Program Leader;
Assistant Attending Physician, Leukemia Service;
Chair, Quality Assessment, Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Aaron D. Goldberg, MD, PhD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center

Mrinal M. Gounder, MD
Physician Ambassador, India and Asia;
Associate Attending Physician, Sarcoma Medical Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center

Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician, Gynecologic Medical Oncology Service
Memorial Sloan Kettering Cancer Center

Malin Hultcrantz, MD, PhD
Assistant Attending Physician, Myeloma Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medicine

Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service & Early Drug Development Service 
Memorial Sloan Kettering Cancer Center

Thomas J. Kaley, MD
Chief, Neuro-Oncology and Cancer Neurology Service;
Vice Chair for Clinical Research, Department of Neurology; 
Chair, Institutional Review Board (IRB-C);
Associate Attending Neuro-Oncologist
Memorial Sloan Kettering Cancer Center

Avi Leader, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center

Grace E. Linder, MD
Director, Education Programs;
Assistant Director, Transfusion Medicine Service; 
Assistant Attending Pathologist
Memorial Sloan Kettering Cancer Center


Robert Maki, MD, PhD
Attending Physician, Member,Sarcoma Medical Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Anita Mamtani, MD, FACS
Surgical Site Director, MSK Bergen; 
Assistant Attending Surgeon, Breast Service
Memorial Sloan Kettering Cancer Center

Simon Mantha, MD, MPH
Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center

Michael J. Mauro, MD
Attending Physician, Member, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center

Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center

Michael D. Offin, MD
Co-Director, Mesothelioma Program;
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology;
Chair, Human Research Protection Program and Institutional Review Board;
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research;
Section Head, Hepatopancreaticobi;
Attending Physician, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Michael A. Postow, MD
Chief, Melanoma Service;
Co-Director, Melanoma Disease Management Team
Memorial Sloan Kettering Cancer Center

Raajit K. Rampal, MD, PhD
Director, Center for Hematologic Malignancies;
Director, Myeloproliferative Neoplasms Program;
Associate Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center

Gregory J. Riely, MD, PhD
Ning Zhao and Ge Li Chair in Lung Cancer Research;
Vice Chair, Clinical Research; 
Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center

Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical Center

Rachel Sanford, MD
Associate Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center

Craig Sauter, MD
Director, Blood and Marrow Transplant Program
Cleveland Clinic

Susan K. Seo, MD
Director, Antibiotic Management Program; 
Attending Physician, Infectious Disease Service
Memorial Sloan Kettering Cancer Center 
Professor of Clinical Medicine, Weill Cornell Medical College


Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs, Department of Medicine;
Attending Physician, Genitourinary Oncology Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Gerald A. Soff, MD
Chief, Classical Hematology Service
University of Miami Health System/Sylvester Comprehensive Cancer Center
Soffer Clinical Research Building 


Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service & Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Eytan M. Stein, MD
Chief, Leukemia Service;
Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center

Meghan C. Thompson, MD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center

Anna M. Varghese, MD
Associate Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Cy R. Wilkins, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center

Jeffrey Zwicker, MD
Chief, Hematology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the live activity March 7-10, 2025 and are listed under the 'Faculty' tab here.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Paul A Hamlin, MD
MSK
Activity Co-Director, Faculty
Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Beigene (Relationship has ended)|Consulting Fee-ADC Therapeutics (Relationship has ended)|Consulting Fee-Karyopharm (Relationship has ended)|Grant or research support-Janssen
David Ilson, MD, PhD
MSK
Activity Director, Faculty
Consulting Fee-Roche|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Daiichi Sankyo|Consulting Fee-Bayer Corporation|Consulting Fee-AstraZeneca|Advisor-Astellas|Advisor-Taiho|Advisor-AMGEN|Advisor-Lilly|Advisor-Oncolys|Advisor-Regeneron
Alice Zervoudakis, MD
MSK
Conflict of Interest Peer Reviewer
Nothing to disclose
Ghassan K Abou-Alfa, MD, JD, MBA, Professor
MSK
Faculty
Grant or research support-Arcus|Grant or research support-Abbvie|Grant or research support-Agenus|Grant or research support-AstraZeneca|Grant or research support-Atara|Grant or research support-BioNtech|Grant or research support-Bristol-Myers Squibb|Grant or research support-Beigene|Grant or research support-Digestive Care|Grant or research support-Elicio|Grant or research support-Genentech, Inc.|Grant or research support-Helsinn|Grant or research support-Parker Institute|Grant or research support-Pertzye|Grant or research support-Yiviva|Consulting Fee-AstraZeneca|Consulting Fee-Abbvie|Consulting Fee-Ability Pharma|Consulting Fee-Agenus|Consulting Fee-Alligator Biosciences|Consulting Fee-Astellas|Consulting Fee-Arcus|Consulting Fee-Autem|Consulting Fee-Berry Genomics|Consulting Fee-Biontech|Consulting Fee-Celgene|Consulting Fee-Bo|Consulting Fee-Fibrogen|Consulting Fee-Genentech, Inc.|Consulting Fee-J-Pharma|Consulting Fee-Ipsen|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Merus|Consulting Fee-Moma Therapeutics|Consulting Fee-Neogene|Consulting Fee-Novartis AG|Consulting Fee-Regeneron|Consulting Fee-Revolutionary Medicine|Consulting Fee-Servier|Consulting Fee-Syros|Consulting Fee-Tango|Consulting Fee-Vector|Advisor-Tempus|Consulting Fee-Yiviva
Carol Aghajanian, MD
MSK
Faculty
Grant or research support-Abbvie (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)|Grant or research support-Clovis (Relationship has ended)|Grant or research support-AstraZeneca|Grant or research support-Artios|Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Board of Directors Member-GOG Foundation
P. Dayand D Borge Jr., MD, PhD
MSK
Faculty
Nothing to disclose
Lior Braunstein, MD
MSK
Faculty
Nothing to disclose
Andrea Cercek, MD
MSK
Usa
Faculty
Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-GlaxoSmithKline|Advisor-Bayer Corporation|Advisor-Janssen|Advisor-Seagen|Grant or research support-GlaxoSmithKline|Grant or research support-Seagen|Grant or research support-RGenix (Relationship has ended)|Advisor-G1 Therapeutics (Relationship has ended)|Advisor-Pfizer, Inc.|Advisor-Roche|Advisor-Pfizer, Inc.
Alissa Cooper, MD
MSK
Faculty
Advisor-Gilead|Consulting Fee-Daiichi Sankyo|Consulting Fee-Regeneron|Honoraria-CancerGRACE (Relationship has ended)|Honoraria-MJH LifeSciences (Relationship has ended)|Honoraria-Ideology Health (Relationship has ended)|Honoraria-Intellisphere LLC (Relationship has ended)|Honoraria-MedStar Health|Grant or research support-Merck and Company, Inc.|Grant or research support-Monte Rosa|Grant or research support-Abbvie|Grant or research support-Roche|Grant or research support-Amgen|Grant or research support-Daiichi Sankyo
Susanna Curtis, MD, PhD
Icahn School of Medicine at Mount Sinai
Faculty
Nothing to disclose
Joshua Drago, MD
MSK
Faculty
Advisor-AstraZeneca|Consulting Fee-Revelio Therapeutics (Relationship has ended)|Consulting Fee-Intellisphere LLC (Relationship has ended)|Consulting Fee-Biotheranostics (Relationship has ended)|Consulting Fee-Genagon (Relationship has ended)|Consulting Fee-AmMax Bio (Relationship has ended)|Consulting Fee-NuProbe
Lara Dunn, MD
MSK
Faculty
Grant or research support-Regeneron|Advisor-Regeneron|Grant or research support-IMVAQ
Darren Feldman, MD
MSK
Faculty
Grant or research support-Decibel (Relationship has ended)|Grant or research support-Telix, Inc.|Consulting Fee-Telix, Inc.|Consulting Fee-BioNtech (Relationship has ended)|Grant or research support-Exelixis |Consulting Fee-Exelixis (Relationship has ended)|Grant or research support-Bristol-Myers Squibb|Consulting Fee-Xencor (Relationship has ended)|Consulting Fee-Renibus (Relationship has ended)|Consulting Fee-Debiopharm
Devika Gajria, MD
MSK
Faculty
Nothing to disclose
Mark B Geyer , MD
MSK
Faculty
Advisor-Sanofi-Aventis|Grant or research support-Amgen|Grant or research support-Actinium Pharmaceuticals, Inc|Advisor-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Tigen
Aaron D Goldberg, MD
MSK
Faculty
Advisor-Abbvie|Advisor-Bristol-Myers Squibb (Relationship has ended)|Advisor-Remedy Plan|Advisor-Astellas|Advisor-Genentech, Inc. (Relationship has ended)|Honoraria-Dava Oncology|Grant or research support-Aprea (Relationship has ended)|Grant or research support-AROG (Relationship has ended)|Grant or research support-Pfizer, Inc. (Relationship has ended)|Grant or research support-Prelude (Relationship has ended)|Advisor-Daiichi Sankyo (Relationship has ended)|Grant or research support-Aptose (Relationship has ended)|Advisor-Molecular Partners|Grant or research support-Kura Oncology|Review Panel Member-Kura Oncology
Mrinal Gounder, MD
MSK
Faculty
Consulting Fee-Ayala|Consulting Fee-Bayer Corporation (Relationship has ended)|Consulting Fee-Boehringer Ingelheim Vetmedica GmbH (Relationship has ended)|Consulting Fee-Rain Oncology (Relationship has ended)|Consulting Fee-Epizyme (Relationship has ended)|Consulting Fee-Karyopharm (Relationship has ended)|Consulting Fee-Springworks Therapeutics (Relationship has ended)|Consulting Fee-Regeneron (Relationship has ended)|Grant or research support-Ikena (Relationship has ended)|Grant or research support-Tango|Advisor-Kura Oncology|Advisor-Avacta
Rachel Grisham, MD
MSK
Faculty
Advisor-GlaxoSmithKline (Relationship has ended)|Advisor-Natera (Relationship has ended)|Advisor-Corcept (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Advisor-Springworks (Relationship has ended)|Advisor-Verastem (Relationship has ended)
Malin Hultcrantz, MD, PhD
MSK
Faculty
Grant or research support-GlaxoSmithKline|Advisor-GlaxoSmithKline|Grant or research support-Daiichi Sankyo (Relationship has ended)|Advisor-Bristol-Myers Squibb|Grant or research support-Beigene|Advisor-Johnson and Johnson (Relationship has ended)|Grant or research support-Johnson and Johnson|Grant or research support-Abbvie|Grant or research support-Cosette Pharmaceuticals (Relationship has ended)|Grant or research support-The Binding Site |Grant or research support-SpringWorks Therapeutics
Gopakumar Iyer, MD
MSK
Faculty
Advisor-Flare Therapeutics|Grant or research support-AstraZeneca|Grant or research support-Pfizer, Inc.|Consulting Fee-EMD Serono (Relationship has ended)|Advisor-LOXO Oncology|Honoraria-DAVA Oncology (Relationship has ended)|Advisor-Aadi Biosciences
Thomas Kaley, MD
MSK
Faculty
Advisor-Servier (Relationship has ended)
Avi Leader, MD
MSK
Faculty
Honoraria-Leo Pharma (Relationship has ended)
Grace E Linder, MD
MSK
Faculty
Nothing to disclose
Robert G Maki, MD, PhD
MSK
Faculty
Consulting Fee-Peel Therapeutics|Stocks or stock options, excluding diversified mutual funds-Peel Therapeutics|Review Panel Member-Deciphera|Advisor-Boehringer Ingelheim Vetmedica GmbH
Anita Mamtani, MD
MSK
Faculty
Nothing to disclose
Simon Mantha, MD, MPH
MSK
Faculty
Paid consultant-Johnson and Johnson (Relationship has ended)
Michael Mauro, MD
MSK
Faculty
Grant or research support-Novartis AG|Honoraria-Novartis AG|Advisor-Bristol-Myers Squibb|Advisor-Pfizer, Inc.|Grant or research support-Sun Pharma (Relationship has ended)|Grant or research support-Takeda Pharmaceuticals, Inc.|Consulting Fee-Abbvie|Advisor-Enliven|Grant or research support-Enliven|Advisor-Terns|Grant or research support-Terns
Alison Moskowitz, MD
MSK
Faculty
Grant or research support-Seagen|Grant or research support-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Incyte Corporation|Grant or research support-SecuraBio|Honoraria-Seagen|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Merck and Company, Inc.|Honoraria-Affimed|Grant or research support-AstraZeneca
Robert Motzer, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc.|Consulting Fee-Exelixis (Relationship has ended)
Michael Offin, MD
MSK
Faculty
Advisor-Mesothelioma Applied Research Foundation|Honoraria-Jazz Pharmaceuticals (Relationship has ended)|Honoraria-ASTRO (Relationship has ended)|Honoraria-OncLive (Relationship has ended)|Honoraria-Targeted Oncology (Relationship has ended)|Grant or research support-Mesothelioma Applied Research Foundation|Grant or research support-LUNGevity|Grant or research support-Department of Defense
Eileen M O'Reilly, MD
MSK
Faculty
Grant or research support-, AstraZeneca, Arcus, Elicio, Parker Institute, AstraZeneca, Pertzye|Grant or research support-BioNtech|Grant or research support-AstraZeneca|Grant or research support-Arcus|Grant or research support-Parker Institute|Grant or research support-Elicio Therapeutics|Grant or research support-Digestive Care|Advisor-Ipsen|Advisor-Merck and Company, Inc.|Advisor-AstraZeneca|Advisor-Thetis|Advisor-Novartis AG|Advisor-BioNTech|Advisor-Bristol-Myers Squibb|Advisor-Merus|Advisor-Alligator Biosciences|Advisor-Leap Therapeutics|Advisor-Revolution Medicine|Grant or research support-Breakthrough Cancer|Grant or research support-NCI NIH|Advisor-Tango Therapeutics|Grant or research support-Amgen|Grant or research support-Agenus|Advisor-Ikena|Advisor-Moma Therapeutics|Advisor-Regeneron (Relationship has ended)|Advisor-Leap Therapeutics
Michael Postow, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Merck and Company, Inc.|Consulting Fee-Chugai|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Eisai, Inc.|Consulting Fee-Pfizer, Inc.|Grant or research support-Infinity|Grant or research support-Novartis AG|Grant or research support-RGenix|Consulting Fee-Erasca (Relationship has ended)|Consulting Fee-Nektar (Relationship has ended)|Consulting Fee-Replimune (Relationship has ended)
Raajit Rampal, MD, PhD
MSK
Faculty
Advisor-Abbvie|Advisor-Bristol-Myers Squibb|Advisor-Incyte Corporation|Grant or research support-Incyte Corporation|Advisor-Novartis AG (Relationship has ended)|Advisor-GlaxoSmithKline|Advisor-Pharmaessentia|Advisor-SDP|Advisor-Morphosys|Advisor-CTI|Advisor-Servier|Advisor-Zentalis|Advisor-Galectco|Advisor-Kartos|Advisor-Cogent|Advisor-Karyopharm|Advisor-Protagonist
Gregory Riely, MD
MSK
Faculty
Grant or research support-Mirati|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-Eli Lilly and Company|Grant or research support-Roche|Grant or research support-Pfizer, Inc.|Grant or research support-Merck and Company, Inc.|Grant or research support-Novartis AG
Leonard B Saltz, MD
MSK
Usa
Faculty
Nothing to disclose
Rachel Sanford, MD
MSK
Faculty
Nothing to disclose
Craig Sauter, MD
Cleveland Clinic
Faculty
Honoraria-Gilead (Relationship has ended)|Advisor-Caribou (Relationship has ended)|Advisor-Ipsen (Relationship has ended)|Review Panel Member-ono pharmaceuticals|Honoraria-crispr (Relationship has ended)|Honoraria-morphosys (Relationship has ended)|Honoraria-syncopation (Relationship has ended)|Independent Contractor (included contracted research)-NKARTA
Susan Seo, MD
MSK
Faculty
Nothing to disclose
Gunjan Shah , MD, MS
MSK
Faculty
Grant or research support-Johnson and Johnson|Grant or research support-Amgen|Grant or research support-Beyond Spring|Grant or research support-Bristol-Myers Squibb|Grant or research support-GPCR Therapeutics|Review Panel Member-Arcellx
Susan Slovin, MD, PhD
MSK
Faculty
Honoraria-Philips Medical Systems, Inc. (Relationship has ended)|Honoraria-Curio Science|Advisor-PER|Advisor-Foundation Medicine|Honoraria-APTITUDE|Advisor-Johnson and Johnson
Gerald Soff, MD
University of Miami Health System/Sylvester
Faculty
Grant or research support-Amgen|Grant or research support- Sobi|Grant or research support-Anthos Therapeutics|Grant or research support-Dova Pharmaceuticals|Grant or research support- Alpine Immune Sciences|Advisor-Sanofi-Aventis|Advisor-Novartis AG
Zsofia Stadler, MD
MSK
Faculty
Nothing to disclose
Eytan Stein, MD
MSK
Faculty
Advisor-Celgene (Relationship has ended)|Review Panel Member-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Review Panel Member-Epizyme|Advisor-PinotBio|Advisor-Janssen (Relationship has ended)|Advisor-Bristol-Myers Squibb|Advisor-Agios|Advisor-Jazz|Advisor-Menarini (Relationship has ended)|Advisor-Genentech, Inc.|Advisor-Abbvie|Advisor-Neoleukin (Relationship has ended)|Advisor-Gilead|Consulting Fee-Syndax|Advisor-Genesis Therapeutics|Advisor-OnCusp Therapeutics|Advisor-CTI Biopharma (Relationship has ended)|Advisor-Foghorn Therapeutics (Relationship has ended)|Advisor-Servier|Advisor-Calithera (Relationship has ended)|Review Panel Member-Cellectis|Honoraria-Kura (Relationship has ended)|Advisor-Novartis AG|Advisor-Daiichi Sankyo (Relationship has ended)|Advisor-Aptose (Relationship has ended)|Advisor-Syros (Relationship has ended)|Advisor-Astellas (Relationship has ended)|Advisor-Ono Pharma (Relationship has ended)|Advisor-Debipharm (Relationship has ended)|Advisor-Geomab|Advisor-Janpix|Advisor-Jnana|Advisor-Blueprint (Relationship has ended)
Meghan C Thompson, MD
MSK
Faculty
Paid consultant-Beigene|Grant or research support-Beigene|Grant or research support-Genmab|Grant or research support-Abbvie|Grant or research support-Adaptive|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Grant or research support-Genmab (Relationship has ended)|Grant or research support-Nurix Therapeutics (Relationship has ended)|Paid consultant-Janssen|Paid consultant-Loxo Oncology at Lilly (Relationship has ended)|Other: Payment for travel and lodging, honoraria-Dava Oncology (Relationship has ended)|Paid consultant-AstraZeneca (Relationship has ended)|Paid consultant-Abbvie (Relationship has ended)
Anna Mary Varghese, MD
MSK
Faculty
Nothing to disclose
Cy R Wilkins, MD
MSK
Faculty
Advisor-Sanofi-Aventis (Relationship has ended)
Andrew D Zelenetz, MD, PhD
MSK
Faculty
Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Consulting Fee-Roche|Advisor-Bristol-Myers Squibb|Consulting Fee-Gilead|Consulting Fee-AstraZeneca|Grant or research support-Beigene|Consulting Fee-Beigene|Consulting Fee-Novartis AG|Consulting Fee-Abbvie|Consulting Fee-MorphoSys|Other: DMC Member-Bristol-Myers Squibb|Advisor-IPSEN|Advisor-Ono|Advisor-Arvinas|Grant or research support-Arvinas
Jeffrey Zwicker, MD
MSK
Faculty
Review Panel Member-CSL Behring (Relationship has ended)|Review Panel Member-Sanofi-Aventis (Relationship has ended)|Consulting Fee-Perceptive|Consulting Fee-Bioclinica (Relationship has ended)|Advisor-Regeneron|Honoraria-Incyte Corporation

Friday, April 4, 2025
2025 Update in Hematology and Medical Oncology - On Demand
9:00AM - 2:45PM

Saturday, April 5, 2025
Sunday, April 6, 2025
Monday, April 7, 2025
Tuesday, April 8, 2025
Wednesday, April 9, 2025
Thursday, April 10, 2025
Friday, April 11, 2025
Saturday, April 12, 2025
Sunday, April 13, 2025
Monday, April 14, 2025
Tuesday, April 15, 2025
Wednesday, April 16, 2025
Thursday, April 17, 2025
Friday, April 18, 2025
Saturday, April 19, 2025
Sunday, April 20, 2025
Monday, April 21, 2025
Tuesday, April 22, 2025
Wednesday, April 23, 2025
Thursday, April 24, 2025
Friday, April 25, 2025
Saturday, April 26, 2025
Sunday, April 27, 2025
Monday, April 28, 2025
Tuesday, April 29, 2025
Wednesday, April 30, 2025
Thursday, May 1, 2025
Friday, May 2, 2025
Saturday, May 3, 2025
Sunday, May 4, 2025
Monday, May 5, 2025
Tuesday, May 6, 2025
Wednesday, May 7, 2025
Thursday, May 8, 2025
Friday, May 9, 2025
Saturday, May 10, 2025
Sunday, May 11, 2025
Monday, May 12, 2025
Tuesday, May 13, 2025
Wednesday, May 14, 2025
Thursday, May 15, 2025
Friday, May 16, 2025
Saturday, May 17, 2025
Sunday, May 18, 2025
Monday, May 19, 2025
Tuesday, May 20, 2025
Wednesday, May 21, 2025
Thursday, May 22, 2025
Friday, May 23, 2025
Saturday, May 24, 2025
Sunday, May 25, 2025
Monday, May 26, 2025
Tuesday, May 27, 2025
Wednesday, May 28, 2025
Thursday, May 29, 2025
Friday, May 30, 2025
Saturday, May 31, 2025
Sunday, June 1, 2025
Monday, June 2, 2025
Tuesday, June 3, 2025
Wednesday, June 4, 2025
Thursday, June 5, 2025
Friday, June 6, 2025
Saturday, June 7, 2025
Sunday, June 8, 2025
Monday, June 9, 2025
Tuesday, June 10, 2025
Wednesday, June 11, 2025
Thursday, June 12, 2025
Friday, June 13, 2025
Saturday, June 14, 2025
Sunday, June 15, 2025
Monday, June 16, 2025
Tuesday, June 17, 2025
Wednesday, June 18, 2025
Thursday, June 19, 2025
Friday, June 20, 2025
Saturday, June 21, 2025
Sunday, June 22, 2025
Monday, June 23, 2025
Tuesday, June 24, 2025
Wednesday, June 25, 2025
Thursday, June 26, 2025
Friday, June 27, 2025
Saturday, June 28, 2025
Sunday, June 29, 2025
Monday, June 30, 2025
Tuesday, July 1, 2025
Wednesday, July 2, 2025
Thursday, July 3, 2025
Friday, July 4, 2025
Saturday, July 5, 2025
Sunday, July 6, 2025
Monday, July 7, 2025
Tuesday, July 8, 2025
Wednesday, July 9, 2025
Thursday, July 10, 2025
Friday, July 11, 2025
Saturday, July 12, 2025
Sunday, July 13, 2025
Monday, July 14, 2025
Tuesday, July 15, 2025
Wednesday, July 16, 2025
Thursday, July 17, 2025
Friday, July 18, 2025
Saturday, July 19, 2025
Sunday, July 20, 2025
Monday, July 21, 2025
Tuesday, July 22, 2025
Wednesday, July 23, 2025
Thursday, July 24, 2025
Friday, July 25, 2025
Saturday, July 26, 2025
Sunday, July 27, 2025
Monday, July 28, 2025
Tuesday, July 29, 2025
Wednesday, July 30, 2025
Thursday, July 31, 2025
Friday, August 1, 2025
Saturday, August 2, 2025
Sunday, August 3, 2025
Monday, August 4, 2025
Tuesday, August 5, 2025
Wednesday, August 6, 2025
Thursday, August 7, 2025
Friday, August 8, 2025
Saturday, August 9, 2025
Sunday, August 10, 2025
Monday, August 11, 2025
Tuesday, August 12, 2025
Wednesday, August 13, 2025
Thursday, August 14, 2025
Friday, August 15, 2025
Saturday, August 16, 2025
Sunday, August 17, 2025
Monday, August 18, 2025
Tuesday, August 19, 2025
Wednesday, August 20, 2025
Thursday, August 21, 2025
Friday, August 22, 2025
Saturday, August 23, 2025
Sunday, August 24, 2025
Monday, August 25, 2025
Tuesday, August 26, 2025
Wednesday, August 27, 2025
Thursday, August 28, 2025
Friday, August 29, 2025
Saturday, August 30, 2025
Sunday, August 31, 2025
Monday, September 1, 2025
Tuesday, September 2, 2025
Wednesday, September 3, 2025
Thursday, September 4, 2025
Friday, September 5, 2025
Saturday, September 6, 2025
Sunday, September 7, 2025
Monday, September 8, 2025
Tuesday, September 9, 2025
Wednesday, September 10, 2025
Thursday, September 11, 2025
Friday, September 12, 2025
Saturday, September 13, 2025
Sunday, September 14, 2025
Monday, September 15, 2025
Tuesday, September 16, 2025
Wednesday, September 17, 2025
Thursday, September 18, 2025
Friday, September 19, 2025
Saturday, September 20, 2025
Sunday, September 21, 2025
Monday, September 22, 2025
Tuesday, September 23, 2025
Wednesday, September 24, 2025
Thursday, September 25, 2025
Friday, September 26, 2025
Saturday, September 27, 2025
Sunday, September 28, 2025
Monday, September 29, 2025
Tuesday, September 30, 2025
Wednesday, October 1, 2025
Thursday, October 2, 2025
Friday, October 3, 2025
Saturday, October 4, 2025
Sunday, October 5, 2025
Monday, October 6, 2025
Tuesday, October 7, 2025
Wednesday, October 8, 2025
Thursday, October 9, 2025
Friday, October 10, 2025
Saturday, October 11, 2025
Sunday, October 12, 2025
Monday, October 13, 2025
Tuesday, October 14, 2025
Wednesday, October 15, 2025
Thursday, October 16, 2025
Friday, October 17, 2025
Saturday, October 18, 2025
Sunday, October 19, 2025
Monday, October 20, 2025
Tuesday, October 21, 2025
Wednesday, October 22, 2025
Thursday, October 23, 2025
Friday, October 24, 2025
Saturday, October 25, 2025
Sunday, October 26, 2025
Monday, October 27, 2025
Tuesday, October 28, 2025
Wednesday, October 29, 2025
Thursday, October 30, 2025
Friday, October 31, 2025
Saturday, November 1, 2025
Sunday, November 2, 2025
Monday, November 3, 2025
Tuesday, November 4, 2025
Wednesday, November 5, 2025
Thursday, November 6, 2025
Friday, November 7, 2025
Saturday, November 8, 2025
Sunday, November 9, 2025
Monday, November 10, 2025
Tuesday, November 11, 2025
Wednesday, November 12, 2025
Thursday, November 13, 2025
Friday, November 14, 2025
Saturday, November 15, 2025
Sunday, November 16, 2025
Monday, November 17, 2025
Tuesday, November 18, 2025
Wednesday, November 19, 2025
Thursday, November 20, 2025
Friday, November 21, 2025
Saturday, November 22, 2025
Sunday, November 23, 2025
Monday, November 24, 2025
Tuesday, November 25, 2025
Wednesday, November 26, 2025
Thursday, November 27, 2025
Friday, November 28, 2025
Saturday, November 29, 2025
Sunday, November 30, 2025

COURSE MATERIAL: 2025 Update in Hematology and Medical Oncology — On Demand

Once registered for the on-demand program, you may access the course content—including video recordings of the lectures and PDFs of speaker presentations—by clicking the “Click to Access Videos and PDFs” button below. To view a lecture, select the film strip icon next to the title. To view available presentation slides, select the PDF icon.

If the button below displays “Purchase,” please ensure you are signed in with the username and password used at registration, or complete your registration for the program.

Once you’ve completed the program, follow the instructions below to claim credit. The deadline to complete the evaluation and claim credit is November 30, 2025.

Purchase
EVALUATION AND CREDIT INSTRUCTIONS: 2025 Update in Hematology and Medical Oncology — On Demand

To claim CME credit, you must attest to your participation in this on-demand program and complete an evaluation. Please follow the instructions below.

1. Complete an Attestation:

a) Click the 'Attestation' button below.
b) Attest to your participation and then select 'Check Answer'.
c) Next, select 'Submit Results', followed by the 'CME Account' button to be redirected to another page where you can access the evaluation.

2. Complete an Evaluation:

Select the 'Complete Evaluation' button associated with this activity. You can also access the evaluation by selecting 'My CME' in the navigation bar at the top of the page, then choosing 'Evaluations & Certificates'.

3) Download Your Certificate:

Once you have successfully completed an evaluation, a certificate will be available for download on the same page. You can access your certificate anytime by signing in to the MSK CME Portal at msk.org/cme, selecting 'My CME', and then 'Evaluations & Certificates'.

Deadline to complete an evaluation and claim credit: November 30, 2025

Purchase


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center